177 related articles for article (PubMed ID: 8791119)
1. Chemoprevention of breast cancer with fenretinide.
Veronesi U; De Palo G; Costa A; Formelli F; Decensi A
IARC Sci Publ; 1996; (136):87-94. PubMed ID: 8791119
[No Abstract] [Full Text] [Related]
2. [-Results of ongoing breast cancer prevention studies-].
Jungi WF
Arch Gynecol Obstet; 1995; 256 Suppl():S116-21. PubMed ID: 8619644
[No Abstract] [Full Text] [Related]
3. Breast cancer chemoprevention: additional observations.
Singh-Ranger G; Mokbel K
Int J Clin Pract; 2003 Mar; 57(2):155; author reply 155. PubMed ID: 12661805
[No Abstract] [Full Text] [Related]
4. Prospects of chemoprevention of human cancers with the synthetic retinoid fenretinide.
Costa A; Formelli F; Chiesa F; Decensi A; De Palo G; Veronesi U
Cancer Res; 1994 Apr; 54(7 Suppl):2032s-2037s. PubMed ID: 8137334
[TBL] [Abstract][Full Text] [Related]
5. Fenretinide and risk reduction of second breast cancer.
Decensi A; Zanardi S; Argusti A; Bonanni B; Costa A; Veronesi U
Nat Clin Pract Oncol; 2007 Feb; 4(2):64-5. PubMed ID: 17259924
[No Abstract] [Full Text] [Related]
6. Synthetic retinoid fenretinide in breast cancer chemoprevention.
Bonanni B; Lazzeroni M; Veronesi U
Expert Rev Anticancer Ther; 2007 Apr; 7(4):423-32. PubMed ID: 17428163
[TBL] [Abstract][Full Text] [Related]
7. Retinoids in cancer chemoprevention. Clinical trials with the synthetic analogue fenretinide.
Costa A; De Palo G; Decensi A; Formelli F; Chiesa F; Nava M; Camerini T; Marubini E; Veronesi U
Ann N Y Acad Sci; 1995 Sep; 768():148-62. PubMed ID: 8526344
[No Abstract] [Full Text] [Related]
8. [The chemoprevention of breast cancer: an evolving reality].
Lopez M
Clin Ter; 1999; 150(5):323-5. PubMed ID: 10687260
[No Abstract] [Full Text] [Related]
9. Chemoprevention of breast cancer with tamoxifen.
Cuzick J
IARC Sci Publ; 1996; (136):95-109. PubMed ID: 8791120
[No Abstract] [Full Text] [Related]
10. [Breakthrough in breast cancer chemoprevention].
Kahán Z; Thurzó L
Orv Hetil; 2003 Mar; 144(13):597-603. PubMed ID: 12728784
[TBL] [Abstract][Full Text] [Related]
11. Cancer risk factors for selecting cohorts for large-scale chemoprevention trials.
Greenwald P
J Cell Biochem Suppl; 1996; 25():29-36. PubMed ID: 9027595
[TBL] [Abstract][Full Text] [Related]
12. Chemoprevention of breast cancer.
De Palo G; Costa A; Formelli F; Del Vecchio M; Marubini E; Veronesi U
In Vivo; 1993; 7(6B):577-80. PubMed ID: 8193278
[TBL] [Abstract][Full Text] [Related]
13. Relationships between plasma insulin-like growth factor-I and insulin-like growth factor binding protein-3 and second breast cancer risk in a prevention trial of fenretinide.
Decensi A; Veronesi U; Miceli R; Johansson H; Mariani L; Camerini T; Di Mauro MG; Cavadini E; De Palo G; Costa A; Perloff M; Malone WF; Formelli F
Clin Cancer Res; 2003 Oct; 9(13):4722-9. PubMed ID: 14581342
[TBL] [Abstract][Full Text] [Related]
14. Adiponectin: a risk biomarker and attractive target for chemoprevention.
Fabian CJ
J Clin Oncol; 2012 Jan; 30(2):124-6. PubMed ID: 22162567
[No Abstract] [Full Text] [Related]
15. Quality control for HPLC assay and surrogate end point biomarkers from the fenretinide (4-HPR) breast cancer prevention trial.
Formelli F
J Cell Biochem Suppl; 2000; 34():73-9. PubMed ID: 10762018
[TBL] [Abstract][Full Text] [Related]
16. [Chemoprevention of breast cancer. Clinical trials in pharmacological prevention].
Ricart JJ
Medicina (B Aires); 2004; 64(1):66-72. PubMed ID: 15034961
[TBL] [Abstract][Full Text] [Related]
17. Re: Vitamin A analogue for breast cancer prevention: a grade of F or incomplete?
Meyskens FL
J Natl Cancer Inst; 2000 Feb; 92(3):274-5. PubMed ID: 10655448
[No Abstract] [Full Text] [Related]
18. Chemoprevention clinical trials: it is time to turn success into progress.
Brown PH
Cancer Epidemiol Biomarkers Prev; 2007 Aug; 16(8):1531-2. PubMed ID: 17684123
[No Abstract] [Full Text] [Related]
19. Chemoprevention of breast cancer.
Costa A; Sacchini V; Bonanni B; D'Aiuto G
Eur J Cancer Prev; 1994 Jul; 3(4):361-4. PubMed ID: 7950891
[No Abstract] [Full Text] [Related]
20. SERMs in chemoprevention of breast cancer.
Gasco M; Argusti A; Bonanni B; Decensi A
Eur J Cancer; 2005 Sep; 41(13):1980-9. PubMed ID: 15964182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
